Cork gets 210 jobs through MSD Brinny expansion

Cork gets 210 jobs through MSD Brinny expansion
The Brinny MSD plant. Pic: Dan Linehan

MORE than 200 jobs are to be created in the latest employment boost for Cork after pharmaceutical giant MSD announced a €280 investment in their Irish operations.

MSD, known as Merck in the UK, will be hiring 210 people at their Brinny facility, outside Kinsale, to meet demand for medicine products for lung cancer, melanoma, hepatitis C and rheumatoid arthritis.

Jobs Minister Mary Mitchell O'Connor said the announcement will contribute to the spread of jobs development outside of the capital.

“MSD has been at the cutting edge of biopharmaceutical innovation over recent years and their Irish operations are at the heart of many of the company's exciting new products. It is particularly gratifying that this expansion and additional job creation will take place in two regional locations, thereby strengthening the Government's efforts to ensure balanced industrial development around the country,” she said.

The company develops, tests and manufactures biologics, specialising in the fermentation, purification and sterile filling of biotech products that fight common diseases.

Biologics are genetically-engineered proteins made from human genes.

They will be hiring 210 people at their Brinny facility to meet demand for medicine products for lung cancer, melanoma, hepatitis C and rheumatoid arthritis.

The company will also hire 120 people for its Carlow facility and Jobs Minister Mary Mitchell O'Connor said the announcement will contribute to the spread of jobs development outside of the capital.

“MSD has been at the cutting edge of biopharmaceutical innovation over recent years and their Irish operations are at the heart of many of the company's exciting new products. It is particularly gratifying that this expansion and additional job creation will take place in two regional locations, thereby strengthening the Government's efforts to ensure balanced industrial development around the country,” she said.

Martin Shanahan, CEO of IDA Ireland said, “MSD’s decision to invest in its Irish operations across a number of regional locations further strengthens Ireland’s positioning as a global destination for manufacturing excellence in biopharmaceuticals. It is pleasing that MSD continues to evolve, grow and innovate from Ireland to continue to meet patient needs around the world.” MSD already employ more than 1,600 people at four locations – Cork, Carlow, Dublin and Tipperary – and has been in the country for the last 50 years. The company had a turnover of €4.7bn last year.

Ger Brennan, managing director of MSD Human Health in Ireland said that investment in Ireland over the last five decades has positioned MSD as a significant player in responding to the world’s most vital, unmet health needs.

“Our existing portfolio and future pipeline ensure current and future employees can operate at the cutting edge of science and technology. Our Irish sites are involved in the production of over 50% of MSD’s global top 20 products, exporting to over 60 countries worldwide.” Details on the jobs at MSD are available at http://www.msd.ie/careers

More in this section

Sponsored Content